Ovid Therapeutics, Inc. (OVID)
1.625
+0.06
(+3.50%)
USD |
NASDAQ |
Dec 10, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Free Cash Flow: -37.93M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AnaptysBio, Inc. | -145.42M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| MannKind Corp. | 42.74M |
| Cassava Sciences, Inc. | -83.91M |
| Cidara Therapeutics, Inc. | -132.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.87M |
| Cash from Investing (Quarterly) | 5.053M |
| Cash from Financing (Quarterly) | 0.015M |
| Free Cash Flow Per Share (Quarterly) | -0.181 |
| Free Cash Flow to Equity (Quarterly) | -12.54M |
| Free Cash Flow to Firm (Quarterly) | -12.87M |
| Free Cash Flow Yield | -32.84% |